Living Well has been doing research for the best practices to assist and support people with Alzheimer’s. Now we have good news.
In an article by Shirley Wang, in the Wall Street Journal on April 15, 2010, we learned that “…companies specializing in medical imaging are pushing to develop chemical agents to detect Alzheimer’s disease from brain scans, a process that one day may make it possible to predict who will suffer from the progressive ailment before symptoms appear.
Avid Radiopharmaceuticals Inc., a tiny imaging company based in Philadelphia, and multinationals like Bayer, AG and General Electric Co., are among those working on imaging compounds to help doctors spot signs of the memory-robbing disease. Such chemical compounds would be a first of their kind and would help their makers tap into the multibillion dollar Alzheimer’s diagnostic market. These diagnostic tools will be important to developing new treatments as well. Many experimental Alzheimer’s treatments appear to work better in patients with less severe forms of the disease but are too weak to have an effect on patients by the time they are diagnosed today…” Read more